OC and ECAR were measured using an XF96 oxymeter (Seahorse Biosciences, North Billerica, MA, USA). hASCs of donors not related to the RNA-Seq analysis were seeded and differentiated in 96-well XF96 assay plates. Baseline, dibutyril-cAMP (Sigma-Aldrich cat#D0627) stimulated, β-guanidinopropionic acid (Sigma-Aldrich cat#G6878), and oligomycin (Enzo Life Sciences, Farmingdale, NY, USA cat#ALX-380-037) inhibited OC and ECAR were recorded. As the last step, cells received a single bolus dose of Antimycin A (Sigma-Aldrich cat# U8674) at 10 μM final concentration for baseline correction. The oxygen consumption rate (OCR) and ECAR were normalized to protein content and normalized readings were shown. For statistical analysis, relative OC and ECAR levels were determined to compare basal, cAMP stimulated and oligomycin inhibited (both in unstimulated and stimulated cells) OCRs/ECARs of each sample to the basal OCR/ECAR of untreated SC white adipocytes [6 (link),7 (link),26 (link)].
Free full text: Click here